Cargando…

Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study

While severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes serious morbidity and mortality in humans (coronavirus disease 2019, COVID-19), there is an enormous range of disease outcomes following virus exposures. Some individuals are asymptomatic while others succumb to virus infectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sealy, Robert E., Hurwitz, Julia L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398386/ https://www.ncbi.nlm.nih.gov/pubmed/34442723 http://dx.doi.org/10.3390/microorganisms9081643

Ejemplares similares

SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses
por: Schmidt, Katja G., et al.
Publicado: (2021)

SARS-CoV-2, “common cold” coronaviruses’ cross-reactivity and “herd immunity”: The razor of Ockham (1285-1347)?
por: Petrosillo, Nicola
Publicado: (2020)

Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses
por: Wang, Ruofan, et al.
Publicado: (2021)

Patients with Common Cold Coronaviruses Tested Negative for IgG Antibody to SARS-CoV-2
por: Brecher, Stephen M., et al.
Publicado: (2020)

Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray
por: Khan, Saahir, et al.
Publicado: (2020)

Targets and cross-reactivity of human T cell recognition of Common Cold Coronaviruses
por: Tarke, Alison, et al.
Publicado: (2023)

Targets and cross-reactivity of human T cell recognition of common cold coronaviruses
por: Tarke, Alison, et al.
Publicado: (2023)

Humoral cross-reactivity towards SARS-CoV-2 in young children with acute respiratory infection with low-pathogenicity coronaviruses
por: Dhochak, Nitin, et al.
Publicado: (2022)

Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses
por: Wang, Ruofan, et al.
Publicado: (2020)

In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2
por: Signer, Johanna, et al.
Publicado: (2020)

Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses
por: Ma, Zhongren, et al.
Publicado: (2020)

Coronaviruses and SARS-COV-2
por: HASÖKSÜZ, Mustafa, et al.
Publicado: (2020)

Author Correction: In vitro virucidal activity of Echinaforce(®), an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2
por: Signer, Johanna, et al.
Publicado: (2020)

Characterization of SARS‐CoV‐2 and common cold coronavirus‐specific T‐cell responses in MIS‐C and Kawasaki disease children
por: Hsieh, Li‐En, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: O’Leary, Valerie Bríd, et al.
Publicado: (2020)

Efficient disinfection of SARS-CoV-2-like coronavirus, pseudotyped SARS-CoV-2 and other coronaviruses using cold plasma induces spike protein damage
por: Qin, Hongbo, et al.
Publicado: (2022)

A cluster of tertiary transmissions of 2019 novel coronavirus (SARS-CoV-2) in the community from infectors with common cold symptoms
por: Kim, Nam Joong, et al.
Publicado: (2020)

Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response
por: Lin, Chun-Yang, et al.
Publicado: (2022)

Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4(+) T-cell response with pre-primed responses directed against common cold coronaviruses
por: Westphal, Tim, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
por: Pal, Mahendra, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (Coronaviridae)
por: Peiris, Malik
Publicado: (2021)

Immunoinformatics Identification of the Conserved and Cross-Reactive T-Cell Epitopes of SARS-CoV-2 with Human Common Cold Coronaviruses, SARS-CoV, MERS-CoV and Live Attenuated Vaccines Presented by HLA Alleles of Indonesian Population
por: Gustiananda, Marsia, et al.
Publicado: (2022)

Mental health consequences of infections by coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
por: Khan, Suliman, et al.
Publicado: (2020)

The relation between avian coronaviruses and SARS-CoV-2 coronavirus
por: Al-Khalaifah, Hanan, et al.
Publicado: (2022)

Distinct SARS-CoV-2 antibody reactivity patterns in coronavirus convalescent plasma revealed by a coronavirus antigen microarray
por: Assis, Rafael, et al.
Publicado: (2021)

Survival of SARS-CoV-2 and bovine coronavirus on common surfaces of living environments
por: Watanabe, Maiko, et al.
Publicado: (2022)

Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study
por: Fillmore, Nathanael R., et al.
Publicado: (2022)

Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2
por: Rajasekharan, Sreejith, et al.
Publicado: (2021)

Epidemiology of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Wei, Maoti, et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)
por: Park, Su Eun
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review
por: Feng, Wei, et al.
Publicado: (2020)

Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2)
por: Maveddat, Ashley, et al.
Publicado: (2020)

JMM Profile: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Inglis, Timothy J. J., et al.
Publicado: (2021)

SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) INFECTION: AN EPIDEMIOLOGICAL REVIEW
por: Buowari, D.Y., et al.
Publicado: (2021)

Biology of the SARS-CoV-2 Coronavirus
por: Mingaleeva, Rimma N., et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus (SARS, SARS CoV)
por: McFee, R.B.
Publicado: (2020)

A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV)
por: Noor, Rashed
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) coinfection: A unique case series
por: Elhazmi, Alyaa, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics Should Inform Policy
por: Cevik, Muge, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ssupc1s0scfa69hgegb3jms97b